Regarding article by Earl and Sullivan.
Moss
R B
RB
D003550:Cystic Fibrosis / Q000276:immunology*; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000209:etiology*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000139:chemically induced*; D007262:Infusions, Intravenous; D014031:Tobramycin / Q000009:adverse effects*
D014031:Tobramycin